|Articles|June 17, 2021
- Pharmaceutical Commerce - June 2021
- Volume 16
- Issue 2
Pharmaceutical Commerce - June 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce June 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
Building a better supply chainover 4 years ago
Staring down supply chain disruptionover 4 years ago
Automation for the peopleover 4 years ago
RFID on the rise again in pharmaover 4 years ago
People, production, and prioritiesover 4 years ago
The march to DSCSA interoperabilityover 4 years ago
Plan of attack for small company supplier negotiationsover 4 years ago
Building a future pandemic blueprintover 4 years ago
2021 Pharma Traceability Vendor Directoryover 4 years ago
Algorithms and accountabilityNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lilly Agreement With Trump Administration Reshapes Patient Access to GLP-1 Obesity Medicines
2
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
3
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
4
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
5
